Report Overview
Report Summary
Summary
Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy.
North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.
In 2020, the global Preimplantation Genetic Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Preimplantation Genetic Testing market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2020-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market segment by Application, the market can be split into
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
The study objectives of this report are:
To study and forecast the market size of Preimplantation Genetic Testing in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Preimplantation Genetic Testing are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Preimplantation Genetic Testing market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table Of Contents
Table of Contents
Preimplantation Genetic Testing Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Preimplantation Genetic Testing
1.1 Preimplantation Genetic Testing Market Overview
1.1.1 Preimplantation Genetic Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Preimplantation Genetic Testing Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Preimplantation Genetic Testing Market by Type
1.3.1 Preimplantation Genetic Screening
1.3.2 Preimplantation Genetic Diagnosis
1.4 Preimplantation Genetic Testing Market by End Users/Application
1.4.1 Maternity Centers & Fertility Clinics
1.4.2 Hospitals, Diagnostic Labs, and Service Providers
1.4.3 Research Laboratories & Academic Institutes
2 Global Preimplantation Genetic Testing Competition Analysis by Players
2.1 Preimplantation Genetic Testing Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Illumina
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Thermo Fisher
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Agilent Technologies
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Perkinelmer
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Coopersurgical
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Abbott Laboratories
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Natera
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Rubicon Genomics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.8.5 Recent Developments
3.9 Oxford Gene Technology
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.9.5 Recent Developments
3.10 Yikon Genomics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Preimplantation Genetic Testing Revenue (Value) (2017-2020)
3.10.5 Recent Developments
3.11 Scigene
3.12 Beijing Genomics Institute
3.13 Good Start Genetics
3.14 Invicta Genetics
3.15 Combimatrix
3.16 Genea Limited
3.17 Progenesis
4 Global Preimplantation Genetic Testing Market Size by Type and Application (2017-2020)
4.1 Global Preimplantation Genetic Testing Market Size by Type (2017-2020)
4.2 Global Preimplantation Genetic Testing Market Size by Application (2017-2020)
4.3 Potential Application of Preimplantation Genetic Testing in Future
4.4 Top Consumer/End Users of Preimplantation Genetic Testing
5 North America Preimplantation Genetic Testing Development Status and Outlook
5.1 North America Preimplantation Genetic Testing Market Size (2017-2020)
5.2 North America Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
6 Europe Preimplantation Genetic Testing Development Status and Outlook
6.1 Europe Preimplantation Genetic Testing Market Size (2017-2020)
6.2 Europe Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
7 China Preimplantation Genetic Testing Development Status and Outlook
7.1 China Preimplantation Genetic Testing Market Size (2017-2020)
7.2 China Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Preimplantation Genetic Testing Development Status and Outlook
8.1 Rest of Asia Pacific Preimplantation Genetic Testing Market Size (2017-2020)
8.2 Rest of Asia Pacific Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Preimplantation Genetic Testing Development Status and Outlook
9.1 Central & South America Preimplantation Genetic Testing Market Size (2017-2020)
9.2 Central & South America Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Preimplantation Genetic Testing Development Status and Outlook
10.1 Middle East & Africa Preimplantation Genetic Testing Market Size (2017-2020)
10.2 Middle East & Africa Preimplantation Genetic Testing Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Preimplantation Genetic Testing Market Size (Value) by Regions (2021-2027)
11.1.1 North America Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.1.2 Europe Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.1.3 China Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Preimplantation Genetic Testing Revenue and Growth Rate (2021-2027)
11.2 Global Preimplantation Genetic Testing Market Size (Value) by Type (2021-2027)
11.3 Global Preimplantation Genetic Testing Market Size by Application (2021-2027)
12 Preimplantation Genetic Testing Market Dynamics
12.1 Preimplantation Genetic Testing Market Opportunities
12.2 Preimplantation Genetic Testing Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Preimplantation Genetic Testing Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Preimplantation Genetic Testing Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source